| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_baee372c55802742f9582e25c15ff11a |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-437
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-04 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-04 |
| filingDate |
2018-01-19^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_446d24bd5400c9b84102f4a5a1bc2c83
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b1d496252644d830fe5632416693a53d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9e2a98c37ee69e41ba563cf65a1d8c19
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_377d14aeeee5160cb1214080fd3dbd5c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0382a654bc15d245db186df0a6f542c2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1e8da413d671aff1977e0c2a6394a4e0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dbdd925f6a2be5c9428c2cead73afb29 |
| publicationDate |
2018-07-26^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2018208593-A1 |
| titleOfInvention |
4-Azaindole Derivatives |
| abstract |
4-Azaindole derivatives which are modulators of muscarinic acetylcholine receptor (mAChR) M1 and which may be effective for the prevention or disease modifying or symptomatic treatment of cognitive deficits associated with neurological disorders such as Alzheimer-type dementia (AD) or dementia with Lewy bodies (DLB), and a pharmaceutical composition comprising a 4-azaindole derivative as an active ingredient. |
| priorityDate |
2013-10-01^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |